RFI-641, a potent respiratory syncytial virus inhibitor. - Wikidata - awgldk - TriplyDB

RFI-641, a potent respiratory syncytial virus inhibitor.

RFI-641, a potent respiratory syncytial virus inhibitor.

http://www.wikidata.org/entity/Q34113730

about

Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design Pharmacokinetics-pharmacodynamics of a respiratory syncytial virus fusion inhibitor in the cotton rat model.Animal pneumoviruses: molecular genetics and pathogenesis.Viral load drives disease in humans experimentally infected with respiratory syncytial virus Optimization of potent and selective quinazolinediones: inhibitors of respiratory syncytial virus that block RNA-dependent RNA-polymerase complex activity.Inhibition of respiratory syncytial virus fusion by the small molecule VP-14637 via specific interactions with F protein.The quest for an efficacious antiviral for respiratory syncytial virus.Oral efficacy of a respiratory syncytial virus inhibitor in rodent models of infection.Intranasal administration of maleic anhydride-modified human serum albumin for pre-exposure prophylaxis of respiratory syncytial virus infection Orally active fusion inhibitor of respiratory syncytial virus Antivirals and antiviral strategies.In search of a small-molecule inhibitor for respiratory syncytial virus.Antiviral activity and molecular mechanism of an orally active respiratory syncytial virus fusion inhibitor.Respiratory syncytial virus entry inhibitors targeting the F protein.Emerging drugs for respiratory syncytial virus infection.Targeting RSV with vaccines and small molecule drugs.Novel therapies for an old virus: treatment of RSV infections in the 21st Century.Dendrimers Based on [1,3,5]-Triazines.

P2860

Q26822988-D7A4F037-618F-4D45-B4D2-D72A57E7D765 Q27021304-16CC4029-6AF9-4E4A-94F8-A9DC53E4F24C Q34290125-6B17FE00-DD98-42B0-88BD-1F9DEEC8EB52 Q34313560-335C2B71-510D-40AA-8BAA-479E02965052 Q34402459-1FD6F101-089B-4286-A5FE-9A58F13FDE4E Q34796481-C34D3DA6-58D8-414B-8CDA-3CDC9A9DCE23 Q34975477-AEDCFE79-6726-40B6-80C7-CAE58F8991E8 Q35115949-84EF038E-2AE2-497D-9F41-7CD02F290247 Q35124942-2DE7737B-F013-495E-8F90-4CD6E3FF31FD Q35160026-9ECB0C50-F540-4C0D-911F-DD2309A650EE Q35547902-D2C605C3-392A-4A92-AA1E-18817EF3120A Q35889586-15F9CDEE-272F-4A34-8EBC-467CE3497914 Q35917503-EDE53C8C-42FD-4F33-AA50-61217A3C09F5 Q36024617-2D77717B-5EF5-4964-920E-50B6E41563FE Q36586879-718E0013-5EA2-4FF5-B347-350913F47872 Q37250650-FCE7001C-55C5-4087-949A-858B7809F65C Q37328584-BBAD57C7-56B2-4B73-B7E9-AA7D1B57F574 Q37626071-D0C05AA7-06EA-4F2C-9B64-F9469623F079 Q42682043-59AA1E2C-C915-411F-B4B5-A703DE35BF54

P2860

RFI-641, a potent respiratory syncytial virus inhibitor.

http://www.wikidata.org/entity/Q34113730

description

2002 nî lūn-bûn

@nan

2002 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մարտին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

RFI-641, a potent respiratory syncytial virus inhibitor.

@ast

RFI-641, a potent respiratory syncytial virus inhibitor.

@en

RFI-641, a potent respiratory syncytial virus inhibitor.

@nl

type

label

RFI-641, a potent respiratory syncytial virus inhibitor.

@ast

RFI-641, a potent respiratory syncytial virus inhibitor.

@en

RFI-641, a potent respiratory syncytial virus inhibitor.

@nl

prefLabel

RFI-641, a potent respiratory syncytial virus inhibitor.

@ast

RFI-641, a potent respiratory syncytial virus inhibitor.

@en

RFI-641, a potent respiratory syncytial virus inhibitor.

@nl

P1433

Q34113730-2DED0CDA-1A1E-443A-8971-C7EEF3BF77E4

P1476

Q34113730-0CDE2CCC-3B87-425F-8293-3456E57C0C8C

P2093

Q34113730-039FE141-79C5-4A53-A5B3-BF1FAA762457

Q34113730-57A0BCF1-2944-487E-AFE7-517C13F5F93E

Q34113730-6C4ABCB9-6F3D-4CAA-92DA-4FCBFF747C6F

Q34113730-72C1A581-549D-498E-A9DC-4B54544105C8

Q34113730-86AC1FC9-031B-436D-8785-0A929C32ABD3

Q34113730-9D4B7EBD-69CC-4BBC-91B1-388383F2D311

Q34113730-9D6B2B24-6857-419B-9A9B-FC5CA535E89F

Q34113730-A671DD34-20BC-461F-90EF-F9BA01783A92

Q34113730-C91E9729-9DCD-4EE2-9447-4E3EA9E8503B

Q34113730-D93DA7E0-E801-4D3E-B7D0-2F50685270E9

P2860

Q34113730-07ACFA28-3EB1-4D8C-826D-45C397DAD3E5

Q34113730-44243399-FE8E-445D-826C-DBB61F36C0D5

Q34113730-44854259-D449-40CE-B82D-D25F792161D9

Q34113730-4B5399C2-F610-4449-9969-5786E848FFF0

Q34113730-518B6586-DC11-494F-A6D2-F881049B6809

Q34113730-51FB25BF-3A62-4A8B-96CE-01DFAD075AE7

Q34113730-52A4F867-084D-4FA5-9D6C-E23999BC67DC

Q34113730-55E7B12D-EB54-487F-9DA5-54997221E6E6

Q34113730-57593ACD-8D30-4FBB-9641-B5FD108DC615

Q34113730-5DC4BFE9-BC49-4B4F-B67B-DFAC9A74ABD5

P304

Q34113730-924CB8B4-4169-4A59-A999-CF78E9A05C5C

P31

Q34113730-B2444295-1CF0-46E5-B095-77487C438544

P356

Q34113730-D6FC4E79-66FB-4339-AC37-B51200990902

P407

Q34113730-CDB8FA8E-2604-4754-A9A5-B17C12403C28

P433

Q34113730-E440C40B-C5B7-4BB4-8610-88B01DEDAE46

P478

Q34113730-F9044438-E045-45D5-AC66-59AD8DC3EF98

P50

Q34113730-3E0B4B3A-A0FC-4B64-8464-6F85C9FF3C57

P577

Q34113730-7E2AEB44-5393-4CB5-927D-6286D1A0A9DD

P698

Q34113730-2E2B59B2-4850-469C-BE65-3A4E4D3258BB

P932

Q34113730-5BA0C378-1A5B-44F2-8814-14C7E2422943

P356

AAC.46.3.841-847.2002

P1433

Antimicrobial Agents and Chemotherapy

P1476

RFI-641, a potent respiratory syncytial virus inhibitor.

@en

P2093

Antonia A Nikitenko

http://www.w3.org/2001/XMLSchema#string

Aron Buklan

http://www.w3.org/2001/XMLSchema#string

Boris Feld

http://www.w3.org/2001/XMLSchema#string

Bryan O'Hara

http://www.w3.org/2001/XMLSchema#string

Clayton C Huntley

http://www.w3.org/2001/XMLSchema#string

Gregory Prince

http://www.w3.org/2001/XMLSchema#string

John F O'Connell

http://www.w3.org/2001/XMLSchema#string

Philip Wyde

http://www.w3.org/2001/XMLSchema#string

Susan Quartuccio

http://www.w3.org/2001/XMLSchema#string

Thomas R Jones

http://www.w3.org/2001/XMLSchema#string

P2860

Structural characterization of the human respiratory syncytial virus fusion protein core

Recent progress in antiviral chemotherapy for respiratory syncytial virus infections.

Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment, and prevention.

Respiratory syncytial virus: A continuing culprit and conundrum.

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.

Novel anti-RSV dianionic dendrimer-like compounds: design, synthesis and biological evaluation.

Respiratory syncytial virus infection in adults

The pathogenesis of respiratory syncytial virus infection in cotton rats

Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse.

Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion

P304

841-847

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.46.3.841-847.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11850270

http://www.w3.org/2001/XMLSchema#string

P932

127488

http://www.w3.org/2001/XMLSchema#string